Gedeborg, R. (2022) “Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study”, Acta Oncologica, 61(3), pp. 328–332. doi: 10.1080/0284186X.2021.2023215.